Showing results (61-70 of 163) with videos related to

Sort By:
Pageof 17
Blood Advances|October 25, 2019
The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterationsAnca Franzini, Anthony D Pomicter, Dongqing Yan, et al.
Blood|June 15, 2006
Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinationsHeather A Bradeen, Christopher A Eide, Thomas O'Hare, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2014
Response monitoring, tolerability, and effectiveness of imatinib treatment for chronic myeloid leukemia in a retrospective research databaseDavid D Stenehjem, Frederick Albright, Kuan-Ling Kuo, et al.
Blood|August 15, 2012
Effects of plerixafor in combination with BCR-ABL kinase inhibition in a murine model of CMLAnupriya Agarwal, Angela G Fleischman, Curtis L Petersen, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Bioluminescence Assay of Lysine Deacylase Sirtuin ActivityAlexandria N Van Scoyk, Orlando Antelope, Anca Franzini, et al.
Analytical Biochemistry|November 28, 2023
Comparison of colorimetric, fluorometric, and liquid chromatography-mass spectrometry assays for acetyl-coenzyme ADaniel S Kantner, Emily Megill, Anna Bostwick, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2015
Structural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitorsMonika A Davare, Nadeem A Vellore, Jacob P Wagner, et al.
Leukemia|March 21, 2008
Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemiaD W Sherbenou, O Hantschel, L Turaga, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2013
Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cellsManabu Kurokawa, Takahiro Ito, Chih-Sheng Yang, et al.
Oncotarget|May 1, 2018
Similar expression profiles in CD34+ cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinibAmi B Patel, Thoralf Lange, Anthony D Pomicter, et al.
Pageof 17